DE69433978D1 - Methode der spezifischen abschaltung von genen durch dna-methylierung - Google Patents
Methode der spezifischen abschaltung von genen durch dna-methylierungInfo
- Publication number
- DE69433978D1 DE69433978D1 DE69433978T DE69433978T DE69433978D1 DE 69433978 D1 DE69433978 D1 DE 69433978D1 DE 69433978 T DE69433978 T DE 69433978T DE 69433978 T DE69433978 T DE 69433978T DE 69433978 D1 DE69433978 D1 DE 69433978D1
- Authority
- DE
- Germany
- Prior art keywords
- genes
- dna methylation
- specific shutdown
- shutdown
- specific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/334—Modified C
- C12N2310/3341—5-Methylcytosine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPL933893 | 1993-06-11 | ||
AUPL933893 | 1993-06-11 | ||
PCT/AU1994/000314 WO1994029461A1 (en) | 1993-06-11 | 1994-06-10 | Method for specific silencing of genes by dna methylation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69433978D1 true DE69433978D1 (de) | 2004-10-07 |
DE69433978T2 DE69433978T2 (de) | 2005-08-25 |
Family
ID=3776965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69433978T Expired - Fee Related DE69433978T2 (de) | 1993-06-11 | 1994-06-10 | Methode der spezifischen abschaltung von genen durch dna-methylierung |
Country Status (5)
Country | Link |
---|---|
US (1) | US5840497A (de) |
EP (1) | EP0707653B1 (de) |
AU (1) | AU675333B2 (de) |
DE (1) | DE69433978T2 (de) |
WO (1) | WO1994029461A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
WO1996002555A1 (en) | 1994-07-15 | 1996-02-01 | The University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
US5874416A (en) * | 1997-11-07 | 1999-02-23 | Sheikhnejad; Gholamreza | RAS antisense inhibition |
DE10032529A1 (de) * | 2000-06-30 | 2002-02-07 | Epigenomics Ag | Diagnose von bedeutenden genetischen Parametern innerhalb des Major Histocompatibility Complex (MHC) |
WO2001073001A2 (en) * | 2000-03-24 | 2001-10-04 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Establishment of cellular manipulations which enhance oligo-mediated gene targeting |
US20040006036A1 (en) * | 2000-04-12 | 2004-01-08 | Gmr, A Delaware Corporation | Silencing transcription by methylation |
CA2312051A1 (en) | 2000-07-13 | 2002-01-13 | Quebepharma Inc. | Methylated nucleotide regulation of gene expression |
US20040224405A1 (en) * | 2003-05-06 | 2004-11-11 | Dharmacon Inc. | siRNA induced systemic gene silencing in mammalian systems |
US8815599B2 (en) * | 2004-06-01 | 2014-08-26 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
US7807647B2 (en) * | 2004-06-01 | 2010-10-05 | Pronai Therapeutics, Inc. | Methods and compositions for cancer therapy |
US20050287667A1 (en) * | 2004-06-01 | 2005-12-29 | Pronai Therapeutics, Inc. | Methods and compositions for the inhibition of gene expression |
EP1957044B1 (de) | 2005-12-01 | 2013-03-13 | Pronai Therapeutics, Inc. | Amphotere liposomen |
US8067163B2 (en) * | 2008-06-09 | 2011-11-29 | National Chung Cheng University | Determination of the biological function of a target gene in a cell |
US9023819B2 (en) | 2008-06-09 | 2015-05-05 | National Chung Cheng University | Treatment of a disease or a condition associated with aberrant gene hypomethylation by a method involving tailored epigenomic modification |
US20100257634A1 (en) * | 2009-04-03 | 2010-10-07 | Venganza Inc. | Bioassay for gene silencing constructs |
WO2023122805A1 (en) | 2021-12-20 | 2023-06-29 | Vestaron Corporation | Sorbitol driven selection pressure method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0402402B1 (de) * | 1988-02-26 | 1995-12-27 | Worcester Foundation For Biomedical Research, Inc. | Hemmung von htlv-iii durch exogene oligonukleotide |
AU4036693A (en) * | 1992-04-15 | 1993-11-18 | Commonwealth Scientific And Industrial Research Organisation | Immortalisation of human cells by gene silencing |
US5874416A (en) * | 1997-11-07 | 1999-02-23 | Sheikhnejad; Gholamreza | RAS antisense inhibition |
-
1994
- 1994-06-10 EP EP94918237A patent/EP0707653B1/de not_active Expired - Lifetime
- 1994-06-10 US US08/937,583 patent/US5840497A/en not_active Expired - Fee Related
- 1994-06-10 DE DE69433978T patent/DE69433978T2/de not_active Expired - Fee Related
- 1994-06-10 AU AU69653/94A patent/AU675333B2/en not_active Ceased
- 1994-06-10 WO PCT/AU1994/000314 patent/WO1994029461A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP0707653A4 (de) | 2002-01-30 |
AU675333B2 (en) | 1997-01-30 |
AU6965394A (en) | 1995-01-03 |
WO1994029461A1 (en) | 1994-12-22 |
EP0707653A1 (de) | 1996-04-24 |
US5840497A (en) | 1998-11-24 |
EP0707653B1 (de) | 2004-09-01 |
DE69433978T2 (de) | 2005-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69433978D1 (de) | Methode der spezifischen abschaltung von genen durch dna-methylierung | |
NO960408D0 (no) | DNA sekvenseringsenzymer | |
EE9600097A (et) | Geenitranskriptide võrdlev analüüs | |
FI954329A (fi) | Farmaseuttisina aineina käytettäviä nukleiinihappoja | |
DE69323983D1 (de) | Methode zur Modifizierung des Fettdruckes von Buchstaben | |
DK0658198T3 (da) | Multicistroniske ekspressionsenheder samt deres anvendelse | |
NO985804D0 (no) | DNA-sekvens som koder fystase av mikroorganismer | |
DE69426956D1 (de) | Nachweis von Mycobakterien durch Nukleinsäure-Multiplexamplifizierung | |
NO954217D0 (no) | Guanosinrike antivirus-oligonukleotider | |
DE69424522D1 (de) | Methode zur resuspendierung von zellreichen konzentraten | |
DE4496581T1 (de) | Nucleinsäure-Sequenzierungsgele | |
NO964628D0 (no) | DNA-sekvenser | |
DE69226763D1 (de) | Härten von fluoroelastomeren | |
DE69400036D1 (de) | Reinigung von Pentafluorethan. | |
DE69415085D1 (de) | Promotor DNA Fragment von coryneformen Bakterien | |
FI970832A (fi) | Biologisen materiaalin, kuten nukleiinihapon, erottamiseen käytettävä laite | |
DE69715552D1 (de) | O-Ringe von ionisch härtbare Fluorelastomere | |
DE69329398D1 (de) | Zusammensetzungen zum Entfernen von Kesselstein | |
DE59510532D1 (de) | Aufschluss von bakterienzellen durch phagenlysine | |
DE69320264D1 (de) | Dekodieren von Seriendaten | |
DE68926025D1 (de) | Methode zur Herstellung von alpha-Amylase hemmenden Substanzen aus Weizen | |
DE69433352D1 (de) | Überexpression von einzelsträngigen dna molekülen | |
ES2187939T3 (es) | Moleculas aisladas de acido nucleico codificantes de miembros de la familia ssx y utilizaciones de las mismas. | |
NO980994D0 (no) | Substituerte fosfinsyreforbindelser og deres anvendelse som farmasöytika | |
DE69402076D1 (de) | Herstellung von nukleinsäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |